Premenstrual disorders

  title={Premenstrual disorders},
  author={Kimberly Ann Yonkers and Michael K Simoni},
  journal={American Journal of Obstetrics and Gynecology},
  • K. Yonkers, M. Simoni
  • Published 29 May 2017
  • Medicine, Psychology, Biology
  • American Journal of Obstetrics and Gynecology

Tables from this paper

Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
  • Khalida Itriyeva
  • Psychology, Medicine
    Current problems in pediatric and adolescent health care
  • 2022
Modern views on treatment of premenstrual syndrome
Among the large number of drugs claimed for the treatment of PMS and PMDD, the so-called alternative therapy deserves special attention, in which several methods have a worthy evidence base for positive effects.
Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps
More systematic research with uniformly defined and prospectively assessed subgroups of PME in larger epidemiological and clinical samples is needed to receive reliable prevalence estimates and information on the clinical impact of PMe of mood disorders, and to uncover underlying mechanisms.
Premenstrual syndrome: a review of the literature
The article presents a review of the literature and studies that assessed the effectiveness of various treatment options (antidepressants, hormone therapy, lifestyle modification and herbal therapy).
Premenstrual dysphoric disorder is associated with the longer length from clitoris to urethra
Atypical high prenatal androgen exposure might predispose individuals to be susceptible to PMDD.
Investigation of auditory potentials and cognitive impairment in premenstrual syndrome
In this study, it is aimed to reveal if cognitive functions are affected or not in PMS and if the subjects are affected, to explain this situation by an objective diagnostic test.
Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study
Women with GAD were more likely to have Premenstrual dysphoric disorder and their anxiety, depression, and irritability should be intervened not only in the luteal phase, but also in the follicular phase.
The Influence of Depression on Biased Diagnosis of Premenstrual Syndrome and Premenstrual Dysphoric Disorder by the PSST Inventory
The present study utilized an Item Response Theory analysis to examine the predictive utility of the Premenstrual Symptom Screening Tool (PSST) in women with and without depression and found that fatigue, depressed mood, feeling overwhelmed, anxiety/tension, and decreased interest in everyday activities were the best predictors of PMS.
Association of Premenstrual Syndrome with Adiposity and Nutrient Intake Among Young Indian Women
PMS was associated with anthropometric parameters, nutrient intake, and dietary preference, and showed correlation with the intake of calorie-rich foods, sweets, and fried salted snacks, whereas consumption of oilseeds alleviated its incidence.


Premenstrual Dysphoric Disorder: Epidemiology and Treatment
Recent literature on potential contributors to premenstrual dysphoric disorder’s pathophysiology, including neurosteroids and stress, are presented, and potential treatment targets are explored.
Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
The effectiveness and safety of non-contraceptive oestrogen-containing preparations in the management of PMS in women of reproductive age with PMS diagnosed by at least two prospective cycles without current psychiatric disorder was determined.
The Hormonal Causes of Premenstrual Tension
My attention has been increasingly directed to a large group of women who are handicapped by premenstrual disturbances of manifold nature, in whom grave systemic disorders manifest themselves predominantly during the premen menstruation.
Epidemiology of premenstrual symptoms and disorders
Premenstrual symptoms are a frequent source of concern to women during their reproductive lives and moderate to severe symptoms impact on their quality of lives.
Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.
These data support the role of altered serotonergic transmission in the efficacy of SSRI treatment for premenstrual dysphoric disorder.
Premenstrual syndromes: overview from a methodologic perspective.
The authors offer recommendations to both investigators and clinicians for more careful observation and documentation of the relationship between mood disorders and the menstrual cycle.
Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China.
Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets.
The combined cohort suggest that 4 symptoms are linked with impairment from PMDD symptoms, which is informative for DSM-5 in that the most symptomatic period typically includes the few days before through the first 3 days of menses rather than only the premenstrual phase.
Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
Luteal phase treatment in women with dysphoric PMS produced significant improvements in depression, impairment, and global ratings compared with placebo and was equivalent in efficacy to sertraline given during the entire menstrual cycle.
Premenstrual depression predicts future major depressive disorder
The assessment of premenstrual depression has validity in identifying women at risk for future MDD, even when a retrospective instrument, PAF, is utilized for such assessment.